drug companies

Johnson & Johnson Hit With $4.69 Billion Loss in Baby Powder-Ovarian Cancer Case

Jul 13, 2018
Austin Kirk/Flickr

The legal assault on Johnson & Johnson and its signature baby powder reached new heights today, when a state court jury in Missouri found the company responsible for the ovarian cancers of 22 women, and ordered the drug and consumer products giant to pay $4.69 billion in compensatory and punitive damages to the cancer victims or their survivors.

The verdict by the jury of six men and six women in St. Louis Circuit Court was by far the largest yet in the mushrooming baby powder litigation.

Credit: WFIU/WTIU

Over the last six years, enough opioids were shipped to the state of Missouri to give every resident 260 pills.

The finding comes from a report released Thursday by Sen. Claire McCaskill, D-Mo. It's the latest in a series of investigations by the senator into the role of drugmakers, distributors and other industry players in fueling the opioid epidemic.

Creative Commons/Pixabay

The manufacturer of a drug linked to Indiana's 2015 HIV outbreak spent more than $200,000 in 2016 promoting its opioid-based pain medication to doctors.

FDA Launches Criminal Investigation Into Unauthorized Herpes Vaccine Research

Apr 12, 2018
Al Drago/CQ Roll Call

The Food and Drug Administration has launched a criminal investigation into research by a Southern Illinois University professor who injected people with his unauthorized herpes vaccine, Kaiser Health News has learned.

Steve Miller has some customers on offer. Millions of them in fact.

The chief medical officer at Express Scripts, the largest pharmacy benefit manager in the U.S., has been essentially auctioning off his 80 million customers to the drug companies that will give him the best deal.

"Who wants my market share?" Miller says. "Whoever will give me the best price, I will reward you with an enormous amount of market share."

States Limiting Patient Costs for High-Priced Drugs

Jul 6, 2015
Chris Porter via Stockmonkeys.com/ https://creativecommons.org/licenses/by/2.0/

As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to cushion the financial pain for patients who need medicine that can cost up to hundreds of thousands of dollars a year.